Top Stories
-
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
Topic
-
Ten short, animated videos in Spanish about mental well-being and self-care are now available.
Topic
-
Source:
ADAA GotAnxietyJeff Cohen, a clinical psychologist at Columbia, shares an introduction to dialectical behavior therapy (DBT) as a treatment option.
Topic
-
Source:
CGTN AmericaThe advancement of gene editing technology "opens up a whole another world of questions we will increasingly face," Dr. Robert Klitzman said.
Latest News
- November 26, 2019
“If holiday meals are stressful for you, it’s never too early to think ahead," says Columbia Psychiatry’s Dr. Deborah Glasofer.
Topic
- September 20, 2019
Drs. Alex Canetti and Ali Mattu discuss the relationship between anxiety and risk for suicide.
Topic
-
Source:
MedscapeSeptember 12, 2019Drs. Drew Ramsey and Lisa B. Dixon discuss first-episode psychosis and effective interventions.
- September 10, 2019
Dr. Katherine Elkington, Associate Professor of Clinical Psychology (in Psychiatry) at Columbia University, discusses the complex connection between suicide and substance use in adolescents.
Topic
- September 4, 2019
Dr. Blake Zakarin discusses the relationship between sleep, mental health, and suicide in adolescents and steps we can all take to improve the quality of our sleep.
Topic
- August 28, 2019
Dr. Gary Brucato, the Center of Prevention and Evaluation's Assistant Director, breaks down some of the early warning signs and symptoms of possible emergent psychotic illness.
Topic
-
Source:
MedscapeJune 10, 2019“As we treat more people with ketamine, an unfortunate side effect of that is more exposure, which means that we're going to create more ketamine addicts,” said Dr. Drew Ramsey.
Topic
-
Source:
MD MagazineMarch 20, 2019“What happens that leads people to relapse is that many don’t want to stay on medication and they’re not adherent,” says Dr. Jeffrey A. Lieberman.
- February 8, 2019
The Columbia Ketamine program offers innovative and responsible care for treatment-resistant depression.
Topic
-
Source:
MedscapeOctober 30, 2017Ecstasy "needs to be looked at in a very careful and rigorously controlled way to accrue evidence showing what it can do and what its potential liability is," says Dr. Jeffrey Lieberman.
Topic
